Skip to main content
WOLVES HAND Co., Ltd. logo

WOLVES HAND Co., Ltd. — Investor Relations & Filings

Ticker · 194A ISIN · JP3159860000 T Professional, scientific and technical activities
Open in API
Filings indexed 14 across all filing types
Latest filing 2025-09-26 Regulatory Filings
Country JP Japan
Listing T 194A

About WOLVES HAND Co., Ltd.

https://wolveshand.jp/

WOLVES HAND Co., Ltd. operates a group of veterinary hospitals and pet grooming salons. The company provides a comprehensive range of animal healthcare, from primary care to advanced secondary medical treatments and complex surgeries, often addressing cases beyond the capacity of smaller, individual clinics. It has strategically expanded its network to meet specific regional demands, such as providing high-level secondary care in the Tokyo metropolitan area and elevating the standard of veterinary medicine in underserved regions like Okinawa. In addition to its core clinical operations, the company also manages pet hotels and offers professional development seminars for veterinarians.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings
2025-09-26 Japanese
有価証券報告書－第7期(2024/07/01－2025/06/30)
Annual Report
2025-09-26 Japanese
臨時報告書
M&A Activity Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report) and is submitted to the Kinki Local Finance Bureau ("近畿財務局"). Section 1 explicitly states the reason for filing: the resolution by the Board of Directors on February 5, 2025, to acquire all shares of "株式会社バハティー" (Bahati Co., Ltd.) and make it a subsidiary. This type of filing, reporting a significant corporate action like an acquisition of a subsidiary, corresponds to a major event disclosure required under Japanese financial regulations. Since it is an extraordinary report detailing a specific material event (M&A/Acquisition) and not a routine periodic report (like 10-K or IR), it fits best under the general category for significant, non-standard regulatory disclosures. Given the options, this is a specific regulatory filing concerning a transaction. While it details an M&A event, the document itself is the formal regulatory filing announcing the event, which often falls under the broad 'Regulatory Filings' (RNS) if a more specific M&A code (TAR) is reserved for takeover bids or merger proposals rather than standard subsidiary acquisitions. However, the content is explicitly about acquiring a subsidiary, which is a form of M&A activity. Since the document is a formal regulatory filing (臨時報告書) detailing the acquisition of a subsidiary, the most appropriate specific code is TAR (M&A Activity), as this acquisition is a material transaction. If TAR is strictly for takeover bids, RNS would be the fallback. Given the detailed nature of the acquisition disclosure, TAR is the stronger fit for the underlying event being reported.
2025-02-25 Japanese
臨時報告書
M&A Activity Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kinki Local Finance Bureau ("近畿財務局"). The content explicitly details the absorption merger (吸収合併) of two wholly-owned subsidiaries, effective January 1, 2025. This type of significant corporate action disclosure in Japan, filed outside of the regular periodic reports (like 10-K or IR), falls under the category of a specific material event disclosure. In the provided definitions, there is no direct code for a Japanese 'Extraordinary Report' detailing a merger. However, the document reports on a significant corporate structure change (merger of subsidiaries) and the resulting change in subsidiary status. This is a mandatory regulatory filing concerning a major corporate event. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a specific, non-periodic regulatory disclosure that doesn't fit the other specific categories like M&A (TAR, which usually implies an external bid/takeover) or Capital Change (CAP, which usually implies fundraising/issuance). Since this is a formal, structured regulatory filing reporting a completed corporate action, RNS is the best fit as a general regulatory disclosure category.
2025-02-25 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains Japanese regulatory headers, specifically mentioning "第２四半期報告書" (Second Quarter Report) and referencing the Financial Instruments and Exchange Act ("金融商品取引法"). It includes confirmation statements by the CEO and CFO regarding the appropriateness of the filing for the period covering July 1, 2024, to December 31, 2024. A comprehensive report for a period shorter than a year (half-year/quarterly) is classified as an Interim/Quarterly Report (IR). Although it is a confirmation document related to the report, the content strongly points to the substance of a formal interim filing rather than just an announcement of publication (RPA/RNS). Given the explicit mention of the 'Second Quarter Report' and the confirmation of its contents, the most appropriate classification is Interim / Quarterly Report (IR).
2025-02-14 Japanese
半期報告書－第7期(2024/07/01－2025/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Kinki Finance Bureau under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement for the interim period (July 1, 2024, to December 31, 2024). It is a formal, substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-02-14 Japanese

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.